A Trial of Tocilizumab in ALS Subjects

NCT02469896 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

ALS
Amyotrophic Lateral Sclerosis
Lou Gehrig's Disease
Motor Neuron Disease

Interventions

DRUG: Tocilizumab
OTHER: Placebo

Sponsor

Barrow Neurological Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]